| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 21 |
| 1 | PACLITAXEL | 21 |
| 2 | RIVAROXABAN | 17 |
| 3 | BLEOMYCIN SULFATE | 15 |
| 4 | BENDAMUSTINE HCL | 13 |
| 5 | BLEOMYCIN | 13 |
| 6 | DACARBAZINE | 13 |
| 7 | DOXORUBICIN | 12 |
| 8 | APIXABAN | 11 |
| 9 | HYDROXYUREA | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACARBAZINE | 13 | 0.0017 |
| 1 | AZATHIOPRINE SODIUM | 4 | 0.0016 |
| 2 | BLEOMYCIN SULFATE | 15 | 0.0014 |
| 3 | DINUTUXIMAB | 1 | 0.0012 |
| 4 | BENDAMUSTINE HCL | 13 | 0.0008 |
| 5 | PEGCETACOPLAN | 1 | 0.0005 |
| 6 | HYDROXYUREA | 11 | 0.0005 |
| 7 | LORLATINIB | 3 | 0.0004 |
| 8 | POTASSIUM CITRATE | 2 | 0.0004 |
| 9 | CLADRIBINE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 | 0.0003 |
| 2 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 5 | Factor Xa Inhibitor [EPC] | 37 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 22 | 0.0001 |
| 7 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 27 | 0.0001 |
| 9 | Antimalarial [EPC] | 1 | 0.0001 |